Author: Ali Aghtar

Nirmatrelvir/Ritonavir (Paxlovid) Prescribing

• Post category: Advocacy

OHIP+ for Pharmacy Professionals

• Post category: Professional Resources

Importance of Cyber Insurance in Pharmacy

• Post category: Insurance

OPA Economics Committee Terms of Reference

• Post category: Governance

Audit and Finance Committee Charter

• Post category: Governance

Improvements in OPA Insurance Products

• Post category:  

Board Update – April 21, 2022, Board Meeting Summary

• Post category: Governance

Ontario Government’s Proposed Expansion of Pharmacy Scope of Practice Will Improve Access to Care For All Ontarians

• Post category: Advocacy

Board Update – February 10, 2022, Board Meeting Summary

• Post category: Governance

Member Feature – Andrew Hanna

• Post category: Membership

Townhall: COVID-19 Vaccine Supply and Distribution During the Pandemic

• Post category: Member Only

OPA Suggested Fee Guide for Uninsured Clinical and Professional Pharmacy Services

• Post category: Professional Resources

Board Update – November 25, 2021, Board Meeting Summary

• Post category: Governance

Virtual Townhall – Symptomatic COVID-19 Testing in Pharmacies

• Post category: Advocacy

Ontario Pharmacists Association Responds to Ontario’s Fall Economic Statement

• Post category: Advocacy